Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
PharmAbcine to participate in Jefferies Global Healthcare Conference and BIO International Convention 2022-05-11 20:00
Bridge Biotherapeutics to Announce Updated Data from its Phase 1 Study of BBT-176 in Advanced Non-Small Cell Lung Cancer in an Oral Presentation at IASLC 2022 World Conference on Lung Cancer 2022-05-10 21:00
Nature Medicine Publishes Results from an Investigator-Initiated Trial of CARsgen's CT041 Claudin18.2 CAR T Cells in Gastrointestinal Cancers 2022-05-10 20:50
AffaMed Therapeutics Holds DEXTENZA Launch and Advisory Board Meeting in Macau 2022-05-10 09:00
iNtRON Biotechnology, Inc., Launches New Website 2022-05-09 21:00
OBiO Technology to Present Data on OVersatile™ Platform for Process Development of Herpes Simplex Virus and Vaccinia Virus Products at the 25th ASGCT Annual Meeting 2022-05-09 19:40
AskGene Limited Announces Completion of USD 20 Million Series A Financing Led by Qiming Venture Partners and TF Capital 2022-05-09 11:37
JW Therapeutics to Present Latest Data of Carteyva® at 2022 ASCO Annual Meeting 2022-05-09 09:00
InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers 2022-05-09 08:04
Aravax appoints Dr Brett Haumann to Board of Directors 2022-05-06 21:00
Harbour BioMed Appoints Dr. Alexander A. Zukiwski to its Scientific Advisory Board 2022-05-06 08:00
Kintor Pharma Announces First Patient Dosing in Multi-Regional Global Phase II Clinical Trial of ALK-1 Antibody and Nivolumab Combination Therapy for the Treatment of Advanced Hepatocellular Carcinoma 2022-05-04 20:36
Inmagene Receives FDA's IND Clearance for OX40 Antagonist 2022-05-01 06:00
Gracell Biotechnologies Announces Details of Oral Abstract Presentation at 2022 ASCO Annual Meeting 2022-04-28 22:30
ReviR Therapeutics Announces Dr. David Dornan as Independent Board Director 2022-04-28 22:00
Formosa Pharmaceuticals and AimMax Therapeutics to Present Phase 2 Trials Results of APP13007 for the Treatment after Cataract Surgery at ARVO 2022 Annual Meeting 2022-04-28 20:00
Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in the United Kingdom 2022-04-27 19:40
Samsung Biologics Reports First Quarter 2022 Financial Results 2022-04-27 14:42
RVAC Medicines, a CBC-Incubated mRNA Platform Company, Raises US$140 Million to Expand R&D and Manufacturing Capacity 2022-04-27 10:00
PharmAbcine Announces Positive Results for Its Novel TIE2-Activating Antibody in GLP Toxicology Study 2022-04-26 20:30
1 81 82 83 84 85 222